Adriel-John Ablaza

Abstract 445: Genomic characteristics and response to rucaparib and enzalutamide in the phase 1b RAMP study of metastatic castration-resistant prostate cancer (mCRPC) patients

C. Ryan, V. Assikis, Jim J. Xiao, 2021, Clinical research.

Rucaparib plus enzalutamide in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Pharmacokinetics (PK) and safety data from the phase Ib RAMP study.

D. Morris, C. Ryan, V. Assikis, 2021 .

Fecal Microbiota Transplantation is Safe and Effective in Chronic Pouchitis Patients

S. Lynch, J. Terdiman, Z. Kassam, 2017 .

The Role of Fecal Microbiota Transplantation in Ulcerative Colitis and Crohn's Disease: Results from a Parallel Inflammatory Bowel Disease Cohort Study

S. Lynch, D. Fadrosh, J. Terdiman, 2017 .